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Abstract We have investigated the capability of nanoparticle-
assisted laser desorption ionizationmass spectrometry (NP-LDI
MS), matrix-assisted laser desorption ionization (MALDI) MS,
and gas cluster ion beam secondary ion mass spectrometry
(GCIB SIMS) to provide maximum information available in
lipid analysis and imaging of mouse brain tissue. The use of
Au nanoparticles deposited as a matrix for NP-LDIMS is com-
pared to MALDI and SIMS analysis of mouse brain tissue and
allows selective detection and imaging of groups of lipid mo-
lecular ion species localizing in the white matter differently
from those observed using conventional MALDI with im-
proved imaging potential. We demonstrate that high-energy
(40 keV) GCIB SIMS can act as a semi-soft ionization method
to extend the useful mass range of SIMS imaging to analyze
and image intact lipids in biological samples, closing the gap
between conventional SIMS and MALDI techniques. The
GCIB SIMS allowed the detection of more intact lipid com-
pounds in the mouse brain compared to MALDI with regular
organic matrices. The 40 keVGCIB SIMS also produced peaks
observed in the NP-LDI analysis, and these peaks were strongly
enhanced in intensity by exposure of the sample to
trifluororacetic acid (TFA) vapor prior to analysis. These MS
techniques for imaging of different types of lipids create a po-
tential overlap and cross point that can enhance the information
for imaging lipids in biological tissue sections.
Keywords Mass spectrometry imaging . Gas cluster SIMS .
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Introduction
Lipids are one of the most abundant biomolecules in the brain
with almost 60% of the brain’s dry weight consisting of lipids.
Lipids have a variety of biological functions and are the main
constituents of cell membranes. In addition, they function as
secondary messengers for cellular signal transduction across
biological membranes, and they are involved in anchoring
proteins within the plasma membrane. Cholesterol,
sphingolipids (sphingomyelin, cerebrosides, sulfatides, gan-
gliosides), and glycerophospholipids (phosphatidycholine,
phosphatidylethanolamine, phosphatidylinositols) are three
major categories of lipid compounds in the brain. The signif-
icant role of lipids in cell signaling and tissue physiology has
been revealed by several studies on neurological disorders
such as Alzheimer’s, Parkinson’s, Niemann-Pick, and multi-
ple sclerosis which all show associated lipid alteration in the
central nervous system [1–3].
Matrix-assisted laser desorption ionization (MALDI) and
secondary ion mass spectrometry (SIMS) are two of the most
widely used mass spectrometric imaging (MSI) techniques
allowing direct probing of the distribution and composition
of various lipid compounds in biological samples in a non-
targeted and label-free manner [4, 5]. For instance, biochem-
ical images of lipid distributions in single cells have been
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obtained using SIMS [6, 7], and both SIMS and MALDI are
capable of showing the distribution of lipids in tissue [8–10].
MALDI has been primarily applied for analyzing intact
lipids and higher mass compounds including proteins in bio-
logical samples [11, 12]. In MALDI, the sample is coated with
a layer of organic matrix, which directly absorbs the laser en-
ergy and is ejected carrying the analyte molecules. The matrix
removes energy from the analyte, reducing fragmentation.
Predominantly intact analyte compounds are therefore pro-
duced by this soft ionization. Several methods of matrix depo-
sition for MALDI imaging are commonly used including auto-
mated spraying (wet matrix deposition provides good extrac-
tion) and sublimation (produces small matrix crystals) [9, 13,
14]. These methods provide good ionization of the analyte
while avoiding large crystal formation that can limit the spatial
resolution with some wet matrix deposition techniques [15]. In
addition, many organic matrices are only suitable for detection
of larger molecules often with m/z >400 due to the interfering
mass peaks derived from the organic matrix below this mass
range [16]. Hence, detection of low mass ions by MALDI can
be difficult. Low mass specific matrices such as carbon nano-
tubes [17], graphite, ionic liquids [18], and some high mass
molecules [19] or use of matrix additives are capable of reduc-
ing background peaks in the low m/z region [20, 21].
Laser desorption ionization (LDI) [16] has recently enjoyed a
resurgence by using nanostructured surfaces such as porous sil-
icon as a support for chemical detection. Ionization and desorp-
tion of the sample are induced by UV laser irradiation of the
surface called desorption-ionization on silicon (DIOS) mass
spectrometry [22]. Nanoparticle-assisted LDI (NP-LDI) has been
used as an alternative to the organic matrix for analyzing and
imaging biomolecules such as fatty acids in tissue improving the
ability to detect lowmass species and produce less complexmass
spectra compared with the standard organic matrices [23–25].
SIMS has been used to identify and localize different lipid
species [26, 27]. The SIMS method has the ability to map
chemical compounds with higher lateral resolution compared
to the other MSI techniques. An advantage of SIMS imaging
is that there is no specific sample pretreatment needed.
However, extensive fragmentation of molecular species is a
disadvantage that makes SIMS best suited for detection of low
mass species m/z <1000. Gas cluster ion beams (GCIBs) are a
relatively new primary ion source for SIMS [28] and have
emerged as a potential tool to improve the detection limit of
SIMS for analyzing intact lipids compared to the conventional
cluster (Bi3
+) and even polyatomic primary ion beams (C60
+)
[29–31]. There are benefits suggested for argon cluster SIMS
of organic samples such as high sputter yield, higher yield for
high mass secondary ions, and less subsurface chemical dam-
age compared to conventional primary ion sources. It has been
recognized that Ar cluster primary ions may lead to a softer
ejection process so that higher mass molecular ions can be
desorbed intact from the surface [29]. Recently, a continuous
high-energy Ar cluster ion beam (40 keV Ar4000
+) has been
used to investigate the potential benefits for lipid analysis and
imaging in fly and mouse brains [32, 33].
Conventional SIMS is a hard ionization technique making it
difficult to image the intact molecular ions of lipids. In contrast,
MALDI and NP-LDI have been used to identify and image
lipid molecular ions in biological tissues. Gold nanoparticles
have been used in lipid molecular ion imaging and compared
with the 2,5-dihydroxybenzoic acid (DHB) matrix using
MALDI-ion mobility in which gold nanoparticles allowed de-
tection of different peaks compared to DHBMALDI [34]. This
motivates us to investigate and compare conventional MALDI
and NP-LDI to the newly developed high-energy gas cluster
primary ion SIMS to image intact lipids.
In this paper, we examine and compare the newly developed
high-energy Ar cluster SIMS to both NP-LDI and MALDI for
the detection of intact lipids and imaging in mouse brain sec-
tions. In order to demonstrate the complementary analysis in the
MSI, lipid molecular ions detected by our optimized gold NP-
LDI [35] and conventional MALDI have been assigned and
compared to those from the 40 keV gas cluster ion beam sec-
ondary ion mass spectrometry (GCIB SIMS). The combined
approach extends the number of lipid species detected by mass
spectrometry imaging techniques in mouse brain samples.
Moreover, we demonstrated the possibility of Ar GCIB in fo-
cusing to sub-5 μm providing the ability to detect the extended
number of molecular lipid species and maximize the informa-
tion obtained from lipids with higher spatial resolution than
conventional MALDI and nanoparticle-assisted laser desorp-
tion ionization mass spectrometry (NP-LDIMS). We show that
the 40 keV GCIB helps to maximize the information obtained
from lipid imaging and is beneficial for high spatial resolution
imaging of lipid pseudo-molecular ions in mouse brain.
Experimental section
Tissue preparation Frozen mouse brain tissue was cryo-
sectioned (Cryostat Leica CM1520) at −20 °C and sagittal
brain slices with 12 μm thickness were thaw mounted on indi-
um tin oxide (ITO)-coated glass microscope slides. Slides were
placed on a cooled (approximately −20 °C) stainless steel hold-
er in a vacuum desiccator and gradually brought to the room
temperature under vacuum for approximately 1 h. Tissue sec-
tions were modified with Au nanoparticles using an airbrush
for NP-LDI analysis. The 10-nm citrate-capped gold nanopar-
ticles (prepared using the citrate reduction method described by
Kimling et al. [36]) suspended in ethanol at 0.6 mg/mL con-
centrationwere sprayed at a distance of 15 cm from the tissue to
avoid wetting the sample [35]. The same Au NP-modified sec-
tion was analyzed sequentially by GCIB SIMS and NP-LDI
(Fig. 1). Different tissues were used for positive and negative
ion modes. For MALDI experiments, serial tissue sections
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from the same brain were collected and DHB (Sigma-Aldrich,
Stockholm, Sweden) matrix was applied by sublimation ac-
cording to the procedure described in our previous study [37].
Briefly, DHB was sublimed at temperature 145 °C under pres-
sure set to 0.8 mbar for total time 10 min.
Mass spectrometric imaging and data analysis SIMS im-
aging was carried out using the J105—3D Chemical Imager
(Ionoptika Ltd, Southampton, UK) equipped with a 40 keV
gas cluster ion beam producing Ar4000
+ (8 % CO2 in Ar). The
continuous stream of secondary ions that are generated are
pulsed into a quadratic field reflectron time-of-flight analyzer
using a linear buncher decoupling the MS from the ion gen-
eration process [38, 39]. A sample of 1200 × 1200 μm2 area
was analyzed in positive ion mode with a 20-μm beam step
(pixel size) and a primary ion fluence of 1.05 × 1012 ions/cm2.
An Ultraflextreme MALDI ToF/ToF mass spectrometer
(Bruker Daltonics, Bremen, Germany) instrument was used for
NP-LDI and MALDI analysis. Imaging data were acquired by
summing 500 shots per array position (pixel) at the laser repeti-
tion rate of 1000 Hz. Both NP-LDI and MALDI imaging were
performed in positive ion mode with 20-μm laser step intervals
(pixel size). Profiling of Au NP-modified brain tissue using NP-
LDI was carried out in negative ion mode and also for investi-
gation of trifluororacetic acid (TFA) sample modification with
NP-LDI. Mass spectra for profiling were obtained by summing
up 1000 shots at a laser repetition rate of 1000 Hz per spot.
TFA modification of the sample was carried as previously
described [40]. Briefly, the tissue slide was placed at 1-cm
distance from a glass petri dish containing 300 μL of TFA
solution 99 % in a sealed desiccator. The tissue was exposed
for 30 min at room temperature.
Results and discussion
We compare NP-LDI, MALDI, and GCIB SIMS to investigate
some of the diverse lipid classes present in regions of mouse
brain tissue. Studying lipids with these MSI techniques pro-
vides complementary spectral and distributional information
of intact lipids in the mouse brain, which can maximize the
available information when tackling biological questions.
Nanoparticle-modified mouse brain sample is compatible
with 40 keV GCIB SIMS analysis A sample section coated
with 10-nm Au nanoparticles was used (a scanning electron
microscopy image confirming the homogeneity of nanoparticle
coverage is shown in the Electronic Supplementary Material
(ESM) Fig. S1) for both SIMS and LDI analysis. SIMS does
not normally need any sample surface modification, although
several studies have reported increased secondary ion signals
when using matrix-enhanced SIMS (ME-SIMS) and metal-
assisted SIMS (MA-SIMS) [41–43]. Previously, we showed
that nanoparticle modification is compatible with SIMS analy-
sis on a standard POPC lipid compound sample [35]. Mouse
brain sections, however, contain a variety of lipid species.
Nanoparticle-free brain, as a control, and nanoparticle-
modified brain sections were analyzed by SIMS using the
Ar4000
+ GCIB, and the spectra were compared to investigate
the compatibility of this sample preparation with SIMS. The
spectra of control and nanoparticle-modified brains are similar,
although there is a moderate enhancement (twofold) in the
secondary ion yield in the modified brain. The result demon-
strates that nanoparticle modification is therefore compatible
with SIMS analysis and does not induce any observable lipid
chemical change in the m/z 700–900 range for the mouse brain
sample (ESM Fig. S2). Likewise, Ar cluster SIMS analysis
prior to the NP-LDI experiment does not make a difference in
the detected peaks using NP-LDI (ESM Fig. S3).
Detection of intact lipid species in the mouse brain using
NP-LDI, MALDI, and GCIB SIMS Nanoparticle modifica-
tion is an alternative to the organic matrix normally used in
MALDI [24, 34, 44]. Using the nanoparticles eliminates back-
ground in the low mass range that can arise from the organic
matrix in MALDI. Furthermore, the same Au nanoparticle-
modified mouse brain section can be analyzed with both Ar
cluster SIMS and NP-LDI techniques to obtain reliable com-
parisons and complementary lipid information. To compare to
the MALDI technique where organic matrices are used, we
analyzed a subsequent tissue slice from the same mouse brain
with sublimed DHB matrix and MALDI. Sublimation was
chosen as the matrix application method as the small crystals
formed are more comparable with the NP addition, and one of
the overall goals of MALDI is to push the spatial resolution to
the sub-cellular scale (even though a 20-μm pixel size was
Fig. 1 Workflow for tissue
imaging using SIMS and NP-
LDI. A mouse brain tissue section
after freeze-drying was modified
with Au nanoparticles using a
spray on procedure. The modified
sample was then subjected to
SIMS and subsequently to NP-
LDI imaging
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selected for this study). Furthermore, advantages of MALDI
matrix sublimation over the spraying methods such as in-
creased signal, minimized lateral diffusion of lipids, and gen-
eration of a uniform thin layer of matrix have been shown by
Robert Murphy, particularly for imaging of lipids in tissue
slices [45]. The Caprioli group has also demonstrated im-
provements in spatial resolution in MALDI MS imaging
employing transmission geometry laser optics, and in this case
sublimation of matrix was also used [46].
Intact lipids in the mass range m/z 700–900 were discretely
imaged in white and gray matter areas of the brain sample with
three approaches; MALDI, NP-LDI, and SIMS. For NP-LDI and
SIMS, thesewere done on the same sample in the two instruments
sequentially. Spectra in the mass range m/z 150–900 from both
gray and white matter are presented in ESM Fig. S4. Although
SIMS is usually considered a harder ionization technique produc-
ing lowmass lipid fragments, comparison of the intact lipid region
of the mass spectra of the high-energy cluster SIMS and MALDI
(Fig. 2a versus b) demonstrates that improved ion yields for high
mass molecular species (intact lipid ions) are obtained with the
cluster SIMS. High mass intact lipid peaks similar to MALDI are
obtained, and furthermore, the GCIB SIMS shows additional
peaks compared toMALDIwhen considering the intact lipidmass
spectra in both gray and white matter regions of brain. NP-LDI
analysis clearly results in different peaks from the similar brain
section analyzed by DHB MALDI analysis, a phenomenon that
was also observed previously [34, 37, 47, 48]. However, in
Fig. 2c, it is clear that the molecular ion peaks obtained using
NP-LDI originate from lipid compounds localized specifically in
the white matter, and there are no peaks detected from the gray
matter area. Peaks acquired by NP-LDI are observed in the GCIB
SIMS mass spectra analyzed from the same sample section. For
the mouse brain samples, GCIB SIMS can be used to analyze and
identify the combination of ion peaks detected by MALDI and
NP-LDI indicating the potential of this approach as a promising
technique for imaging larger and intact lipid species in the brain.
Assignment of the peaks, based on the literature and online
databases, reveals that 40 keV GCIB SIMS and MALDI mass
spectra are dominated by strong peaks from lipids phosphati-
dylcholine (PC) (the base peak in the presented spectra corre-
sponds to POPC, [M + K]+, m/z 798.54), in contrast to NP-
LDI, which mainly produces signals from lipids with m/z
>800 such as galactosylceramide and sphingomyelin species
and does not produce an intact POPC signal. The NP-LDI
result is consistent with our previous work in that NP-LDI
analysis on POPC standard lipid does not show the intact
Fig. 2 Comparison of the mass spectra in the gray and white matter
regions obtained from a brain tissue section within the intact lipid mass
range (m/z 700–900) using a 40 keV Ar4000
+ GCIB SIMS on the
nanoparticle-modified tissue, b MALDI with DHB sublimation, and c
gold NP-LDI. The spectra for all methods were normalized to total ion
counts in the whole spectrum (In SIMS ×109 for gray matter and ×104 for
white matter)
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molecular peak for POPC but instead its fragments are detect-
ed (m/z 184.07 (C5H15NPO4) and m/z 86.09 (C5H12N)) [35].
In NP-LDI analysis of the brain, it appears that POPC (and
probably other intact PCs) is strongly fragmented by the laser
with nanoparticles and thus its molecular ion and most PCs
with m/z <800 do not appear in the NP-LDI mass spectrum.
Therefore, NP-LDI might be a suitable method for selective
analysis of lipid species in the brain, particularly for those
lipids distributing in the white matter area. This especially
includes lipids such as cerebroside and sphingomyelin (with
m/z above 800), which are usually covered by the cholesterol
in the white matter and can hardly be detected in SIMS.
The different ionization processes that occur when using
MALDI with an organic matrix versus NP-LDI might be used
to explain the diverse peaks detected and different mass spectra.
The organic matrix is a low volatility chemical that absorbs
energy from the laser radiation and indirectly couples the ener-
gy to the analyte co-crystallized with thematrix. In NP-LDI, the
mechanism for analyte ionization/desorption is a thermally
driven process. In this mechanism, the excitation of gold nano-
particles can produce heat due to the interactions between elec-
trons in the particles and laser irradiation. The resulting heat is
then transferred to the analytes. In complex biological sample
matrices, the thermal propagation to different molecules is dif-
ferent, and therefore the ionization efficiency is different. This
results in different signal responses of biomolecules and the
variousmass spectra obtained from different samples. The com-
plete fragmentation of the PC lipids to m/z 184.07 and smaller
fragments with the NP-LDI compared with partial fragmenta-
tion in the GCIB SIMS experiment provide an indication as to
the relative energetics of the ion formation processes.
Trifluoroacetic acid sample modification for NP-LDI and
GCIB SIMS in positive ion mode In contrast to MALDI, the
SIMS technique usually does not need as much sample prepara-
tion. However, to improve the ionization ability of higher mass
molecules, there are methods to treat the sample prior to the
SIMS analysis such as organic matrices (matrix enhancement,
ME-SIMS) or metals (metal assisted, MA-SIMS) coating [41].
TFA has been commonly used as a component in MALDI ma-
trix solution and also in desorption electrospray ionization
(DESI) studies [49]. Recently, it was shown that when using
SIMS analysis (on mouse brain) or DHB sublimation, MALDI
(on fly brain) sample modification with TFA vapor exposure is
beneficial for the measurement of intact lipids since it helps to
remove cholesterol in cholesterol-rich samples, and it might
slightly improve the lipid signals by enhancing ionization [37,
40]. We applied the same method of TFA treatment to compare
GCIB SIMS, NP-LDI, and MALDI with DHB analysis when
examining positive ions. In our experiment on the mouse brain,
TFA treatment results in no significant change in lipid intensities
observed using DHB sublimation for MALDI. For NP-LDI
Fig. 3 Mass spectra of the TFA treated sample (top) and without TFA exposure (bottom) using Ar cluster SIMS (a) in comparison with NP-LDI analysis
(b). The spectra for SIMS methods were normalized to number of selected pixels
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analysis, sample modification with TFA increases the intensities
of intact lipid ions in the range m/z 800–900 and additionally it
produces new peaks above m/z 1000, which are not detected
without the TFA modification (Fig. 3). In comparison, when
the GCIB is used for SIMS, the peak intensities are enhanced
significantly, especially for m/z >800 including the lipid region
where NP-LDI produces the most peaks. As the peaks detected
by NP-LDI are only observed in the white matter of the mouse
brain sample, we hypothesize that the TFA removes cholesterol
from the surface of the white matter allowing the other species to
be measured with SIMS. Comparison of the peak at m/z 369
belonging to (cholesterol + H-H2O) between control and TFA-
treated samples indicates that cholesterol content is diminished
by applying TFA (ESM Fig. S5). This is consistent with the
mechanism proposed by Angerer et al. previously [40].
Molecular ion imaging of phospholipid species in the
mouse brain To highlight the differences between detected
peaks with these MSI techniques, two peaks in the mass spectra
from each method NP-LDI (m/z 832.66 and 850.67) and
MALDI (m/z 772.52 and 826.57) were selected (four peaks in
total) and their ion images compared with the same peaks in the
Ar GCIB SIMS mass spectrum without any signal normalization
(Fig. 4a, b). As shown above, in NP-LDI the intact lipids are
only localized in the white matter, we see the sodium adduct of
sphingolipid (C48H91NO8Na) at m/z 832.66 and sphingomyelin
(18:1/24:1) at m/z 835.66. Sphingomyelins are the most abun-
dant sphingolipids in mammalian cell membrane; they are the
main components of the myelin sheath that acts as an isolation
layer around the axons of myelinated neurons. Besides being
components of cell membranes, sphingomyelins act as regulators
for various cellular signaling processes such as cell growth, sig-
nal transduction, and apoptosis [50]. In addition, they are abun-
dant in high-density lipoproteins, and sphingomyelins affect pro-
tein conformation and can therefore regulate the activities of
enzymes, receptors, and transporters [51]. In the white and gray
matter of human brain, the sphingomyelin content is about 7–8%
in each area, whereas in whole rat brain, the content is about 4 %
[52]. Previously,MALDI imaging of themouse brain was used to
show that different sphingomyelins specifically localize in the
gray matter or white matter corresponding to the localization of
ceramide synthase, which is the enzyme that catalyzes the syn-
thesis of the precursor of sphingomyelins—ceramides. For exam-
ple, the sphingomyelins (18:1/24:0) and (18:1/24:1) localize in the
whitemyelin-richmatter, whereas sphingomyelin (18:1/18:0) dis-
tributes in the gray matter [53].
Fig. 4 Ion images (no
normalization (a) and total ion
count (TIC) normalization (b)
(4800 × 4800 μm2)) obtained
from mouse brain tissue using
NP-LDI, MALDI with 20-μm
laser step size, and Ar GCIB
SIMS adjusted to have 20-μm
beam spot size. Dominant peaks
at m/z 832.66 (sphingolipid [M +
Na]+) and m/z 850.67
(cerebroside C48H93NO9 [M +
Na]+) were selected for NP-LDI
for comparison with dominant
peaks at m/z 772.52 (PC (32:0),
[M + K]+) and m/z 826.57 (PC
(36:1), [M + K]+) for MALDI and
Ar GCIB SIMS. NP-LDI images
demonstrate distinct distributions
for lipid species in the white
matter while this is not
distinguishable for MALDI with
DHB. Ar GCIB SIMS shows the
ions localized in both white and
gray matter. The number of
counts in Ar GCIB SIMS for m/z
772.52, m/z 826.57, m/z 832.66,
and m/z 850.67 are 3709, 1763,
1069, and 1176, respectively
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The ion images show that the cerebroside (sodium adduct of
C48H93NO9 at m/z 850.67) is observed by NP-LDI and is
colocalized with the sphingomyelins (18:1/24:0) and (18:1/
24:1) in the white matter (Fig. 4a). Cerebrosides are
glycosphingolipids which are composed of a ceramide con-
nected to a sugar unit [54]. There are two groups of cerebro-
sides, which are the glucocerebrosides (glucosylceramides) and
galatocerebrosides (galatosylceramides). Glucosylceramides
are mainly found in the cytoplasmic surface of the cell mem-
brane, skin, muscle, intestine, and kidney [55, 56], whereas
galactosylceramides are typically present in the brain.
Galactosylceramides are the abundant lipid components of
the neuronal myelin sheath [57]. Cerebrosides function as an-
ticoagulant in the cardiovasculature and in the brain, and are
important regulators for cell differentiation, apoptosis, and sig-
nal transduction, for example galactosylceramides affect the
activities of Ca channels and cell morphology [58, 59]. Thus,
the ability to measure these species with high spatial resolution
and reasonable sensitivity is highly important.
The ion images acquired by Au NP-LDI clearly demon-
strate (without any data normalization) the distribution of de-
tected lipids in the white matter with an enhanced contrast
compared to MALDI with the same 20-μm pixel size using
DHB sublimation which does not show any heterogeneity in
the signal distribution in the ion images (Fig. 4a).
Therefore, to provide clear ion images, data normalization
(versus total ion counts) has been applied to MALDI with
DHB as matrix, and the ion images have been compared to the
NP-LDI images using the same normalization (normalized data
images are shown in Fig. 4b). Comparing the ion images shows
that in contrast to the NP-LDI, the distribution of lipids in the
gray matter, for instance the potassium adduct of PC (32:0) [M +
K]+ ion with m/z 772.52, is more distinctive in MALDI.
Likewise, the ion image of m/z 734.56 indicates the distribution
of protonated peak for PC (32:0) in the gray matter is also more
distinct in comparison with the potassium adduct of this lipid
species in LDI (ESM Fig. S6).
For Ar GCIB SIMS, with the pixel size set to 20 μm for
closer comparison with the MALDI and LDI data, the ion
images of intact lipids without any data normalization clearly
show the distribution of the analytes in both the gray, such as
potassium adduct of PC (32:0) [M+K]+ ion, and white matter,
such as potassium adducts of PC (36:1) [M + K]+,
sphingolipid C48H91NO8 [M + Na]
+, and cerebroside
C48H93NO9 [M + Na]
+ (Fig. 4a).
Fig. 6 Mass spectra of intact lipids acquired from mouse brain tissue
using high-energy Ar cluster SIMS (a) and NP-LDI (b) in negative ion
mode (peak intensity is normalized to the maximum intensity (×100) in
the range m/z 700 to m/z 925). The strong peak in the NP-LDI spectrum
between m/z 775 and m/z 800 is Au4
−
Fig. 5 Overlay ion images of intact PC (32:0) [M + K]+ at m/z 772.52
(red) and sphingolipid C48H91NO8Na [M + Na]
+ at m/z 832.66 (green).
The pixel size was set to 12 μm for image (a) (2400 × 2400 μm2, with the
number of counts 20,337 for m/z 772.52 and 15140 for m/z 832.66) and
3 μm for image (b) (500 × 500 μm2, with the number of counts 9525 for
m/z 772.52 and 9040 for m/z 832.66). The line scan graph was obtained
from image (b) indicates an approximate spatial resolution of 4 μm (c)
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Phosphatidylcholines belong to the glycerophospholipids
group which are the main components of the cell membrane.
The lamellar-shaped PCs mainly distribute in the outer leaflet
of the bilayers of the cell membrane. PCs have been shown to
play important roles in brain function and perturbation of PCs
leads to severe brain disorders and injuries, for instance
Alzheimer’s disease, ischemia, stroke, and schizophrenia [60,
61]. In the rat brain, different PCs have been observed in differ-
ent regions depending on the length and number of double bonds
of fatty acid chains. For example, PC (32:0) at m/z 734 is
Table 1 Positive ion mode
Possible assignments for lipid molecular ion peaks Calculated mass Ar SIMS MALDI NP-LDI Measured mass
Ar SIMS
Δppm
Galactosylceramide (32:1) C38H73NO8K [M + K]
+ 710.4973 + 710.495 −3.23
Phosphatidic acid (34:1) C37H71O8PK [M + K]
+ 713.4523 + 713.4537 1.96
Cerebroside C40H76NO9 [M + H] 714.5519 + 714.5553 4.75
Phosphatidic acid C39H73O8PNa [M + Na]
+ 723.494 + 723.4953 1.79
Phosphatidylcholine (32:0) C39H73O8PK [M + K]
+ 734.5699 + + 734.5677 −2.99
Phosphatidic acid C39H73O8PK [M+K]
+ 739.4679 + 739.4683 0.54
Phosphatidic acid (36:1) C39H75O8PK [M + K]
+ 741.4836 + 741.4826 −1.34
Sphingolipid (18:0) C42H81NO8NA [M + Na]
+ 750.5859 + + 750.5789 −9.32
Phosphatidylcholine fragment 751.52 + + 751.5181 −2.52
Sphingomyelin (18:1/36:1) C41H83N2O6PNA [M + Na]
+ 753.5886 + 753.5873 −1.72
Phosphatidylcholine (32:0) C40H80NO8PNa [M + Na]
+ 756.5519 + + 756.5541 2.9
Phosphatidylcholine (34:2) C42H81NO8 [M + H]
+ 758.5699 + 758.5634 −8.56
Phosphatidylcholine (34:1) C42H83NO8P [M + H]
+ 760.5856 + + 760.5868 1.57
Phosphatidylcholine (34:0) C42H85NO8P [M + H]
+ 762.6012 + 762.5996 −2.09
Phosphatidylinositol (30:1) C39H76O12P [M + H]
+ 767.5074 + 767.5073 −0.13
Sphingomyelin (18:1/36:1)C41H83N2O6PK [M + K]
+ 769.5625 + 769.5614 −1.42
Phosphatidylcholine (32:0) C40H80NO8PK [M + K]
+ 772.5258 + + 772.5251 −0.9
Sphingomyelin (18:1/20:0) C43H87N2O6PNa [M + Na]
+ 781.6199 + + 781.6157 −5.37
Phosphatidylcholine (34:1) C42H82NO8PNa [M + Na]
+ 782.5675 + 782.5678 0.38
Phosphatidylcholine C42H84NO8PNa (34:0) [M + Na]
+ 784.5831 + 784.5833 0.25
Phosphatidylcholine (36:1) C44H87NO8P [M + H]
+ 788.6169 + 788.6164 −0.63
Phosphatidylcholine (34:1) C42H82NO8PK [M + K]
+ 798.5414 + + 798.5426 1.5
Phosphatidylcholine (34:0) C42H84NO8PK [M + K]
+ 800.5571 + 800.554 −3.87
Sphingomyelin (18:1/22:0)C45H91N2O6PNa [M + Na]
+ 809.6512 + + 809.6438 −9.13
Phosphatidylcholine (36:1) C44H86NO8PNa [M + Na]
+ 810.5988 + 810.5941 −5.79
Galactosylceramide (d18:1/23:0) C47H91NO8Na [M + Na]
+ 820.6642 + + 820.6583 −7.18
Phosphatidylcholine (40:4) C48H89NO7P [M + H]
+ 822.6376 + + 822.6394 2.18
Galactosylceramide (d18:0/22:0) C46H91NO8K [M + Na]
+ 824.6381 + + 824.6315 −8
Phosphatidylcholine (36:1) C44H86NO8PK [M + K]
+ 826.5727 + + 826.579 7.62
Sphingolipid C48H91NO8Na [M + Na]
+ 832.6642 + + 832.658 −7.44
Sphingomyelin (18:1/24:1) C47H93N2O6PNa [M + Na]
+ 835.6668 + + 835.6619 −5.86
Phosphatidylcholine (42:1) C47H92NO7PNa [M + Na]
+ 836.6508 + 836.654 3.82
Sphingomyelin (18:1/24:0)C47H95N2O6PNa [M + Na]
+ 837.6825 + + 837.6744 −9.66
Phosphatidylethanolamine (42:3) C47H88NO8PNa [M + Na] 848.6144 + + + 848.619 5.42
Cerebroside C48H93NO9Na [M + Na]
+ 850.6747 + + 850.668 −7.87
Sphingomyelin (18:1/24:1) C47H93N2O6PK [M + K]+ 851.6408 + + 851.6442 3.99
Phosphatidylcholine (41:4) C49H91NO8P [M + H]
+ 852.6482 + 852.6492 1.17
Ceramide (40:0) C46H93NO11P [M + H]
+ 866.6486 + + 866.6437 −5.65
Lipid assignment for mass peaks obtained by NP-LDI, MALDI, and high-energy Ar cluster SIMS in the mouse brain in positive ion mode (Table 1) and
peak assignments for NP-LDI and Ar GCIB SIMS spectra in negative ion mode (Table 2) [26, 40, 48, 66]. The peaks that appear in each MSI technique
are weighted by (+). In Ar GCIB SIMS, the peaks enhanced after TFA modification of the sample are bold. Galactosylceramide (A/B) corresponds to
long chain base (A)/ amide-linked fatty acid (B)
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predominantly localized in the gray matter of the rat brain,
whereas PC (36:1) at m/z 788 is distributed in both gray and
white matter [62, 63]. This correlates to our results, which show
that potassium adduct PC (32:0) [M+K]+ is localized in the gray
matter.
Utilizing the 40 kVAr GCIB for biological imaging pro-
vides benefits including higher secondary ion signal for high
molecular weight species which is beneficial for high spatial
resolution imaging of intact molecular ions such as lipids. To
demonstrate this point, we acquired an image of a TFA-
modified mouse brain section using GCIB SIMS with smaller
beam sizes. Images of intact lipids distributed in the white and
gray matter are shown with pixel sizes of 12 and 3 μm in
Fig. 5 (a and b, respectively). This is a promising advantage
of using GCIB SIMS to perform high spatial resolution (ap-
proximately 4 μm) mapping of high mass intact lipids such as
sphingomyelins, phosphatidylcholines and cerebrosides.
Analysis using Ar GCIB SIMS and NP-LDI in negative
ion mode NP-LDI and SIMS allow the detection of further
lipid species in the negative ion mode. There are also several
methods that have been reported for negative ion lipid analysis
including MALDI using organic matrixes such as α-cyano-4
hydroxycinnamic acid (CHCA), 9-aminoacridine, or 2,5-
DHB [64, 65]. Figure 6 shows mass spectra for NP-LDI and
high-energy Ar cluster SIMS in the negative ion mode con-
taining intact lipid peaks in the range m/z 700–925. The spec-
trum for the high-energy Ar cluster SIMS shows that lipids in
the negative ion mode can be detected similarly to those de-
tected by applying organic matrix (DHB) with washing pro-
cedures (beneficial for peaks enhancement) in MALDI report-
ed in previous studies [65]. Furthermore, in comparison to
NP-LDI (Fig. 6), it is obvious that a lot more peaks are again
observed in the intact lipid molecular range by Ar GCIB
SIMS.
Peak identification and related lipid compound assign-
ment Putative peak assignments, based on literature and data-
base assignments, for mouse brain comparing intact molecular
ions and lipid species identified by GCIB SIMS, NP-LDI, and
MALDI in positive and negative ionmodes are given in Tables 1
and 2. The peaks identified by eachMSI technique are shown by
a plus sign (+). The high-energy Ar4000
+ GCIB can be applied to
identify many of the lipid species observed with MALDI, but
additionally it can be used to detect and imagemolecular species,
for instance PC (34:0) [M + H]+, phosphatidylinositol PI (30:1)
[M + H]+, or cerebroside C40H76NO9 [M + H]
+, in the range of
m/z 700–800 not easily observed with MALDI.
A considerable number of molecular ion adduct peaks in the
NP-LDI spectrum suggest an ability for the Au nanoparticles to
generate cationized ions. Some lipid species in the brain such as
sphingolipid C48H91NO8 [M + Na]
+, sphingomyelin (18:1/
24:1) [M + K]+, or cerebroside C48H93NO9 [M + Na]
+ are
dominantly identified and imaged by NP-LDI, whereas there
are also sodium-cationized pseudo-molecular ion peaks pro-
duced by NP-LDI such as cerebroside C46H89NO9 [M + Na]
+
(m/z 822.64) that are detected with their pronated or molecular
ion peaks in the Ar GCIB SIMS and MALDI spectra. The NP-
LDI dominant peaks are enhanced clearly by analysis with the
GCIB SIMS after TFA modification of the sample. Moreover,
in the negative ion mode, Ar GCIB SIMS also shows the ca-
pability of detecting a wider range of lipids with good signal to
noise comparedwith NP-LDI. Besides lipid compounds includ-
ing sphingolipids (acidic glycosphingolipids and sulfatides) and










778.5138 C40H76SNO11 778.5156 2.31
794.5088 C40H76SNO12 794.5123 4.4
806.5451 C42H80SNO11 806.5457 0.74
850.5739 C44H84SNO12 850.5726 −1.52
862.6077 C46H88SNO11 862.6045 −5.24
876.6234 C47H90SNO11 876.6188 −5.24
878.6026 C46H88SNO12 878.6017 −1.02
888.6234 C48H90SNO11 888.6231 −0.33
890.639 C48H92SNO11 890.6386 −0.44
904.6183 C48H90SNO12 904.6185 0.22




857.5179 C45H78O12P 857.5169 −1.16
885.5492 C47H82O13P 885.5485 −0.79
In negative ionmode, themost dominant peaks detected by both NP-LDI analysis andAr cluster SIMS are shown.
Measured mass obtained from Ar SIMS
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phospholipids that are similarly identified by NP-LDI and
SIMS, other intact lipid peaks in the range m/z 700–875 are
only observed using the Ar GCIB SIMS analysis (detailed
peaks have been assigned in a previous study [40]). In fact,
these results indicate that it is possible to use Ar GCIB SIMS
imaging to analyze the wide range of intact lipid species detect-
ed in the mass range to about 900 m/z by both NP-LDI and
MALDI from mouse brain samples.
Conclusions
GCIB SIMS has been compared to both NP-LDI and MALDI
mass spectrometric imaging techniques in terms of their ability
to analyze and image intact lipids inmouse brain tissue. NP-LDI
gives high signals in the mass range m/z >800 and groups of
intact lipids localized in thewhitematter are selectively detected,
whereasMALDI shows high sensitivity for phosphatidylcholine
lipids in the mass range m/z <800. NP-LDI exhibits superior
potential for ion imaging of the lipid species specifically local-
ized in the white matter compared toMALDI with conventional
organic matrix deposition. In MALDI, there is a need for data
normalization to obtain more distinctive ion images. However,
SIMSwith a 40 keVAr4000
+ GCIB is capable of detecting intact
lipid compounds present in both the white and gray matter areas
of the mouse brain sample in both positive and negative ion
modes similar to the lipid analysis by MALDI, and furthermore
in positive ion mode it is possible to detect more lipid species in
the m/z 700–900 range. In addition, the peaks detected by NP-
LDI were significantly enhanced in the GCIB SIMS spectrum
following TFA exposure. Ar GCIB SIMS provides the ability to
detect a wide range of molecular lipids including those detected
byMALDI and NP-LDI with a beam that is readily focusable to
sub-5 μm which makes it an encouraging technique in bio-
chemical imaging and lipidomics.
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